Ayako Nakamura-Ishizu
   Department   School of Medicine, School of Medicine
   Position   Professor and Division head
Article types Original article
Language English
Peer review Peer reviewed
Title Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells.
Journal Formal name:Cell stem cell
Abbreviation:Cell Stem Cell
ISSN code:18759777/18759777
Domestic / ForeginForegin
Volume, Issue, Page 12(1),pp.49-61
Author and coauthor Takubo Keiyo, Nagamatsu Go, Kobayashi Chiharu I, Nakamura-Ishizu Ayako, Kobayashi Hiroshi, Ikeda Eiji, Goda Nobuhito, Rahimi Yasmeen, Johnson Randall S, Soga Tomoyoshi, Hirao Atsushi, Suematsu Makoto, Suda Toshio
Publication date 2013/01
Summary Defining the metabolic programs that underlie stem cell maintenance will be essential for developing strategies to manipulate stem cell capacity. Mammalian hematopoietic stem cells (HSCs) maintain cell cycle quiescence in a hypoxic microenvironment. It has been proposed that HSCs exhibit a distinct metabolic phenotype under these conditions. Here we directly investigated this idea using metabolomic analysis and found that HSCs generate adenosine-5'-triphosphate by anaerobic glycolysis through a pyruvate dehydrogenase kinase (Pdk)-dependent mechanism. Elevated Pdk expression leads to active suppression of the influx of glycolytic metabolites into mitochondria. Pdk overexpression in glycolysis-defective HSCs restored glycolysis, cell cycle quiescence, and stem cell capacity, while loss of both Pdk2 and Pdk4 attenuated HSC quiescence, glycolysis, and transplantation capacity. Moreover, treatment of HSCs with a Pdk mimetic promoted their survival and transplantation capacity. Thus, glycolytic metabolic status governed by Pdk acts as a cell cycle checkpoint that modulates HSC quiescence and function.
DOI 10.1016/j.stem.2012.10.011
PMID 23290136